(CNM) Core & Main - Overview
Sector: IndustrialsIndustry: Industrial Distribution | Exchange NYSE (USA) | Currency USD | Market Cap: 9.548m | Total Return 0.2% in 12m
Stock: Pipes, Valves, Hydrants, Fittings, Drainage
Total Rating 42
Risk 86
Buy Signal -0.06
| Risk 5d forecast | |
|---|---|
| Volatility | 36.9% |
| Relative Tail Risk | -11.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.13 |
| Alpha | -16.01 |
| Character TTM | |
|---|---|
| Beta | 1.309 |
| Beta Downside | 1.127 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.74% |
| CAGR/Max DD | 0.77 |
EPS (Earnings per Share)
Revenue
Description: CNM Core & Main March 05, 2026
Core & Main Inc. (CNM) distributes water, wastewater, storm drainage, and fire protection products and related services in the United States. The companys product portfolio includes pipes, valves, hydrants, and fittings for underground water infrastructure, as well as storm drainage systems and fire protection components.
CNM also provides smart meter products and solutions, encompassing installation, network infrastructure, and software services. The companys offerings support the maintenance, repair, replacement, and construction of critical infrastructure.
Core & Main serves municipalities, private water companies, and professional contractors across municipal, non-residential, and residential end markets. The distribution sector for construction materials is characterized by a fragmented competitive landscape.
For more detailed financial analysis and performance metrics, consider exploring ValueRay.
Headlines to watch out for
- Infrastructure spending impacts demand for water and wastewater products
- Raw material price fluctuations affect product costs
- Residential and non-residential construction activity drives sales
- Regulatory changes for water infrastructure create market opportunities
- Competition from other distributors pressures pricing
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 441.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA -1.35 > 1.0 |
| NWC/Revenue: 18.31% < 20% (prev 17.03%; Δ 1.28% < -1%) |
| CFO/TA 0.10 > 3% & CFO 617.0m > Net Income 441.0m |
| Net Debt (2.35b) to EBITDA (748.0m): 3.14 < 3 |
| Current Ratio: 2.26 > 1.5 & < 3 |
| Outstanding Shares: last quarter (197.9m) vs 12m ago -1.62% < -2% |
| Gross Margin: 26.93% > 18% (prev 0.27%; Δ 2.67k% > 0.5%) |
| Asset Turnover: 122.2% > 50% (prev 119.7%; Δ 2.48% > 0%) |
| Interest Coverage Ratio: 5.03 > 6 (EBITDA TTM 748.0m / Interest Expense TTM 120.0m) |
Altman Z'' 2.67
| A: 0.22 (Total Current Assets 2.51b - Total Current Liabilities 1.11b) / Total Assets 6.30b |
| B: 0.12 (Retained Earnings 736.0m / Total Assets 6.30b) |
| C: 0.10 (EBIT TTM 604.0m / Avg Total Assets 6.26b) |
| D: 0.17 (Book Value of Equity 732.0m / Total Liabilities 4.25b) |
| Altman-Z'' Score: 2.67 = A |
Beneish M -3.12
| DSRI: 0.95 (Receivables 1.34b/1.38b, Revenue 7.65b/7.44b) |
| GMI: 0.99 (GM 26.93% / 26.61%) |
| AQI: 0.96 (AQ_t 0.53 / AQ_t-1 0.55) |
| SGI: 1.03 (Revenue 7.65b / 7.44b) |
| TATA: -0.03 (NI 441.0m - CFO 617.0m) / TA 6.30b) |
| Beneish M-Score: -3.12 (Cap -4..+1) = AA |
What is the price of CNM shares?
As of March 27, 2026, the stock is trading at USD 49.62 with a total of 2,060,703 shares traded.
Over the past week, the price has changed by +4.46%, over one month by -9.98%, over three months by -8.11% and over the past year by +0.24%.
Over the past week, the price has changed by +4.46%, over one month by -9.98%, over three months by -8.11% and over the past year by +0.24%.
Is CNM a buy, sell or hold?
Core & Main has received a consensus analysts rating of 4.07.
Therefore, it is recommended to buy CNM.
- StrongBuy: 6
- Buy: 4
- Hold: 3
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the CNM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 60.9 | 22.7% |
| Analysts Target Price | 60.9 | 22.7% |
CNM Fundamental Data Overview March 26, 2026
P/E Trailing = 21.8961
P/E Forward = 17.7936
P/S = 1.2298
P/B = 4.5267
P/EG = 1.922
Revenue TTM = 7.65b USD
EBIT TTM = 604.0m USD
EBITDA TTM = 748.0m USD
Long Term Debt = 2.13b USD (from longTermDebt, last quarter)
Short Term Debt = 98.0m USD (from shortTermDebt, last quarter)
Debt = 2.43b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.35b USD (from netDebt column, last quarter)
Enterprise Value = 11.89b USD (9.55b + Debt 2.43b - CCE 89.0m)
Interest Coverage Ratio = 5.03 (Ebit TTM 604.0m / Interest Expense TTM 120.0m)
EV/FCF = 20.68x (Enterprise Value 11.89b / FCF TTM 575.0m)
FCF Yield = 4.83% (FCF TTM 575.0m / Enterprise Value 11.89b)
FCF Margin = 7.52% (FCF TTM 575.0m / Revenue TTM 7.65b)
Net Margin = 5.77% (Net Income TTM 441.0m / Revenue TTM 7.65b)
Gross Margin = 26.93% ((Revenue TTM 7.65b - Cost of Revenue TTM 5.59b) / Revenue TTM)
Gross Margin QoQ = 27.07% (prev 27.21%)
Tobins Q-Ratio = 1.89 (Enterprise Value 11.89b / Total Assets 6.30b)
Interest Expense / Debt = 1.19% (Interest Expense 29.0m / Debt 2.43b)
Taxrate = 22.34% (21.0m / 94.0m)
NOPAT = 469.1m (EBIT 604.0m * (1 - 22.34%))
Current Ratio = 2.26 (Total Current Assets 2.51b / Total Current Liabilities 1.11b)
Debt / Equity = 1.23 (Debt 2.43b / totalStockholderEquity, last quarter 1.98b)
Debt / EBITDA = 3.14 (Net Debt 2.35b / EBITDA 748.0m)
Debt / FCF = 4.08 (Net Debt 2.35b / FCF TTM 575.0m)
Total Stockholder Equity = 1.83b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.05% (Net Income 441.0m / Total Assets 6.30b)
RoE = 24.15% (Net Income TTM 441.0m / Total Stockholder Equity 1.83b)
RoCE = 15.27% (EBIT 604.0m / Capital Employed (Equity 1.83b + L.T.Debt 2.13b))
RoIC = 11.55% (NOPAT 469.1m / Invested Capital 4.06b)
WACC = 8.63% (E(9.55b)/V(11.98b) * Re(10.59%) + D(2.43b)/V(11.98b) * Rd(1.19%) * (1-Tc(0.22)))
Discount Rate = 10.59% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -6.15%
[DCF] Terminal Value 70.44% ; FCFF base≈605.4m ; Y1≈444.7m ; Y5≈254.6m
[DCF] Fair Price = 10.75 (EV 4.37b - Net Debt 2.35b = Equity 2.03b / Shares 188.8m; r=8.63% [WACC]; 5y FCF grow -31.34% → 3.0% )
EPS Correlation: 6.06 | EPS CAGR: 0.59% | SUE: 0.58 | # QB: 0
Revenue Correlation: 38.99 | Revenue CAGR: -0.28% | SUE: 0.15 | # QB: 0
EPS next Quarter (2026-04-30): EPS=0.57 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+0 | Analysts=5
EPS current Year (2027-01-31): EPS=2.58 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+11.2% | Growth Revenue=+3.4%
EPS next Year (2028-01-31): EPS=3.01 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+16.6% | Growth Revenue=+5.3%
[Growth] Implied Growth Rate = 6.0% (Discount Rate 10.6% - Earnings Yield 4.6%)
[Growth] Growth Spread = -5.9% (Analyst 0.1% - Implied 6.0%)
P/E Forward = 17.7936
P/S = 1.2298
P/B = 4.5267
P/EG = 1.922
Revenue TTM = 7.65b USD
EBIT TTM = 604.0m USD
EBITDA TTM = 748.0m USD
Long Term Debt = 2.13b USD (from longTermDebt, last quarter)
Short Term Debt = 98.0m USD (from shortTermDebt, last quarter)
Debt = 2.43b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.35b USD (from netDebt column, last quarter)
Enterprise Value = 11.89b USD (9.55b + Debt 2.43b - CCE 89.0m)
Interest Coverage Ratio = 5.03 (Ebit TTM 604.0m / Interest Expense TTM 120.0m)
EV/FCF = 20.68x (Enterprise Value 11.89b / FCF TTM 575.0m)
FCF Yield = 4.83% (FCF TTM 575.0m / Enterprise Value 11.89b)
FCF Margin = 7.52% (FCF TTM 575.0m / Revenue TTM 7.65b)
Net Margin = 5.77% (Net Income TTM 441.0m / Revenue TTM 7.65b)
Gross Margin = 26.93% ((Revenue TTM 7.65b - Cost of Revenue TTM 5.59b) / Revenue TTM)
Gross Margin QoQ = 27.07% (prev 27.21%)
Tobins Q-Ratio = 1.89 (Enterprise Value 11.89b / Total Assets 6.30b)
Interest Expense / Debt = 1.19% (Interest Expense 29.0m / Debt 2.43b)
Taxrate = 22.34% (21.0m / 94.0m)
NOPAT = 469.1m (EBIT 604.0m * (1 - 22.34%))
Current Ratio = 2.26 (Total Current Assets 2.51b / Total Current Liabilities 1.11b)
Debt / Equity = 1.23 (Debt 2.43b / totalStockholderEquity, last quarter 1.98b)
Debt / EBITDA = 3.14 (Net Debt 2.35b / EBITDA 748.0m)
Debt / FCF = 4.08 (Net Debt 2.35b / FCF TTM 575.0m)
Total Stockholder Equity = 1.83b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.05% (Net Income 441.0m / Total Assets 6.30b)
RoE = 24.15% (Net Income TTM 441.0m / Total Stockholder Equity 1.83b)
RoCE = 15.27% (EBIT 604.0m / Capital Employed (Equity 1.83b + L.T.Debt 2.13b))
RoIC = 11.55% (NOPAT 469.1m / Invested Capital 4.06b)
WACC = 8.63% (E(9.55b)/V(11.98b) * Re(10.59%) + D(2.43b)/V(11.98b) * Rd(1.19%) * (1-Tc(0.22)))
Discount Rate = 10.59% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -6.15%
[DCF] Terminal Value 70.44% ; FCFF base≈605.4m ; Y1≈444.7m ; Y5≈254.6m
[DCF] Fair Price = 10.75 (EV 4.37b - Net Debt 2.35b = Equity 2.03b / Shares 188.8m; r=8.63% [WACC]; 5y FCF grow -31.34% → 3.0% )
EPS Correlation: 6.06 | EPS CAGR: 0.59% | SUE: 0.58 | # QB: 0
Revenue Correlation: 38.99 | Revenue CAGR: -0.28% | SUE: 0.15 | # QB: 0
EPS next Quarter (2026-04-30): EPS=0.57 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+0 | Analysts=5
EPS current Year (2027-01-31): EPS=2.58 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+11.2% | Growth Revenue=+3.4%
EPS next Year (2028-01-31): EPS=3.01 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+16.6% | Growth Revenue=+5.3%
[Growth] Implied Growth Rate = 6.0% (Discount Rate 10.6% - Earnings Yield 4.6%)
[Growth] Growth Spread = -5.9% (Analyst 0.1% - Implied 6.0%)